Skip to Content
U.S. National Institutes of Health
Last Updated: 05/30/14


The NCI Chemical Biology Consortium (CBC) was established in 2009 to facilitate the discovery and development of new agents to treat cancer. The Consortium brings together chemical biologists and molecular oncologists from government, industry, and academia to address unmet needs in therapeutic oncology. Through the CBC and the interactions among the various Participants, the NCI's drug discovery and development pipeline can be active from target identification through proof-of-concept clinical trials.

U.S. Map showing Chemical Biology Consortium (CBC) Member locations The Fragment Discovery Center (FDC at UCSF) SRI International Sanford-Burnham Institute Vanderbilt Institute of Chemical Biology Southern Research Institute Emory Chemical Biology Discovery Center North Carolina Comprehensive Chemical Biology Center Georgetown University Medical Center The NIH Chemical Genomics Center (NCGC) The University of Pittsburgh Specialized Application Center The University of Pittsburgh Chemical Diversity Center University of Minnesota Chemical Diversity Center